Skip to content

Total Assets at other companies

Labcorp Holdings logo
Labcorp HoldingsLH
$19.09B+8.4%
Quest Diagnostics logo
Quest DiagnosticsDGX
$16.67B+5.5%
NeoGenomics logo
NeoGenomicsNEO
$1.35B-15.9%
Veracyte logo
VeracyteVCYT
$1.44B+9.2%
Guardant Health logo
Guardant HealthGH
$1.92B+42.5%
Natera, Inc. logo
Natera, Inc.NTRA
$2.61B+50.9%

Other financials

Income statement

See full
Revenue$200.4M+2.3%
Gross profit$137.6M+2.5%
Operating income-$30.7M-5.9%
Net income-$34.1M-34,000%
EPS (diluted)-$0.36

Balance sheet

See full
Cash & equivalents$126.0M+24.8%
Total debt$211.5M+34.2%
Total equity$337.4M-52.1%

Cash flow

See full
Operating cash flow-$15.7M+3.7%
CapEx$18.8M+181%
Free cash flow-$19.7M+65.1%

Valuation

See full
Market cap$512.85M+13.1%
Enterprise value$598.35M+17.3%
P/S0.6×+0.1×

Profitability

See full
Gross margin70%0.0pp
Operating margin-46.9%-88.3pp
Net margin-48.2%-72.9pp
FCF margin-17%

Returns & leverage

See full
Return on equity-76.7%-98.4pp
Debt / equity0.6×+0.4×
Current ratio2.4×+0.5×

Where this comes from

Reported directly by Myriad Genetics in its filing.

Tagged under the XBRL concept us-gaap:Assets.

The official record: Myriad Genetics’s 10-Q, filed May 6, 2026, on SEC EDGAR. View the filing →

Ask your AI about Myriad Genetics's total assets.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

What is Myriad Genetics's total assets?
Myriad Genetics (MYGN) reported total assets of $673.7M in Q1 2026.
How has Myriad Genetics's total assets changed year-over-year?
Myriad Genetics's total assets decreased by 33.0% year-over-year, from $1.01B to $673.7M.
What is the long-term trend for Myriad Genetics's total assets?
Over 5 years (2020 to 2025), Myriad Genetics's total assets has grown at a -13.0% compound annual growth rate (CAGR), from $1.42B to $706.6M.
What does total assets mean?
The sum of everything the company owns — current assets, property, investments, goodwill, intangibles, and all other assets.